Literature DB >> 18253830

The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer.

Wen-Jin Ding1, Jing-Yuan Fang, Xiao-Yu Chen, Yan-Shen Peng.   

Abstract

This study investigates the varied expression of DNA methyltransferase (DNMT) proteins in gastric cancer (GC) and their relationship with the biological behavior of the tissues. Immunohistochemistry was used to detect the expression of the 3 DNMTs in gastric tissues. We discovered that the positive rates of DNMT1, DNMT3a, and DNMT3b expression in GC tissues were 81.6%, 81.6%, and 68.4%, respectively, and they were significantly higher than those of both para-cancerous (39.5%, 50%, and 44.7%) and normal tissues (10.5%, 10.5%, and 7.9%). DNMT1 was well distributed in the cytoplasm and nuclei of tumor cells or glands, while DNMT3a and 3b were well distributed only in the cytoplasm, as shown by staining a dark brown color. A significant correlation between the DNMT1 and DNMT3a proteins (P < 0.01), a low correlation between DNMT3a and DNMT3b (P < 0.05), and no correlation between DNMT1 and DNMT3b (P > 0.05) were observed. DNMT1 protein expression exhibited no correlation with age, lymphnode metastasis, and also tumor differentiation, but it may have had a correlation with gender. The DNMT3 family was not associated with these factors. Therefore, DNMT overexpression is involved in gastric tumorigenesis, but there is no correlation between the DNMTs and the biological behaviors of tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253830     DOI: 10.1007/s10620-007-0145-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  39 in total

1.  Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis.

Authors:  Y Saito; Y Kanai; M Sakamoto; H Saito; H Ishii; S Hirohashi
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

2.  Transition of mouse de novo methyltransferases expression from Dnmt3b to Dnmt3a during neural progenitor cell development.

Authors:  D Watanabe; K Uchiyama; K Hanaoka
Journal:  Neuroscience       Date:  2006-09-14       Impact factor: 3.590

3.  Nutritional "omics" technologies for elucidating the role(s) of bioactive food components in colon cancer prevention.

Authors:  Cindy D Davis; Norman G Hord
Journal:  J Nutr       Date:  2005-11       Impact factor: 4.798

Review 4.  Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases.

Authors:  Robert Penner; Richard N Fedorak; Karen L Madsen
Journal:  Curr Opin Pharmacol       Date:  2005-10-07       Impact factor: 5.547

5.  Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis.

Authors:  Yasuhiro Yamada; Laurie Jackson-Grusby; Heinz Linhart; Alex Meissner; Amir Eden; Haijiang Lin; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-08       Impact factor: 11.205

6.  Plant foods and risk of gastric cancer: a case-control study in Uruguay.

Authors:  E De Stefani; P Correa; P Boffetta; A Ronco; P Brennan; H Deneo-Pellegrini; M Mendilaharsu
Journal:  Eur J Cancer Prev       Date:  2001-08       Impact factor: 2.497

Review 7.  Cruciferous vegetables and colo-rectal cancer.

Authors:  Anthony Lynn; Andrew Collins; Zoë Fuller; Kevin Hillman; Brian Ratcliffe
Journal:  Proc Nutr Soc       Date:  2006-02       Impact factor: 6.297

8.  DNA methyltransferase and demethylase in human prostate cancer.

Authors:  Samir K Patra; Aditi Patra; Hong Zhao; Rajvir Dahiya
Journal:  Mol Carcinog       Date:  2002-03       Impact factor: 4.784

9.  The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.

Authors:  Mitsuo Sato; Yoshitsugu Horio; Yoshitaka Sekido; John D Minna; Kaoru Shimokata; Yoshinori Hasegawa
Journal:  Oncogene       Date:  2002-07-18       Impact factor: 9.867

10.  Proteomic alteration in gastic adenocarcinomas from Japanese patients.

Authors:  Takahiro Yoshihara; Yoshito Kadota; Yoshiyuki Yoshimura; Yutaka Tatano; Naohiro Takeuchi; Hiroshi Okitsu; Atsushi Umemoto; Takashi Yamauchi; Kohji Itoh
Journal:  Mol Cancer       Date:  2006-12-25       Impact factor: 27.401

View more
  33 in total

1.  FOXA1 positively regulates gene expression by changing gene methylation status in human breast cancer MCF-7 cells.

Authors:  Lu Zheng; Bo Qian; Duo Tian; Tong Tang; Shengyun Wan; Lei Wang; Lixin Zhu; Xiaoping Geng
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma.

Authors:  Zhihong Weng; Dongdong Wang; Wenyue Zhao; Mengqi Song; Faping You; Lian Yang; Libo Chen
Journal:  Exp Ther Med       Date:  2011-06-17       Impact factor: 2.447

3.  Prognostic value of the DNMTs mRNA expression and genetic polymorphisms on the clinical outcome in oral cancer patients.

Authors:  Gordana Supic; Ruzica Kozomara; Katarina Zeljic; Nebojsa Jovic; Zvonko Magic
Journal:  Clin Oral Investig       Date:  2016-03-11       Impact factor: 3.573

4.  Ectopic expression of guanylyl cyclase C and endogenous ligand guanylin correlates significantly with Helicobacter pylori infection in gastric carcinogenesis.

Authors:  Jian-Feng Zhang; Zhen-Biao Mao; Zeng-Li Li; Shi-Min Xue; Hui-Jun Zhu; Hong Zhang; Run-Zhou Ni
Journal:  Med Oncol       Date:  2011-10-05       Impact factor: 3.064

5.  MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer.

Authors:  E K O Ng; W P Tsang; S S M Ng; H C Jin; J Yu; J J Li; C Röcken; M P A Ebert; T T Kwok; J J Y Sung
Journal:  Br J Cancer       Date:  2009-07-28       Impact factor: 7.640

6.  A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma.

Authors:  Hong Fan; Dongsheng Liu; Xuemei Qiu; Fengchang Qiao; Qingxiang Wu; Xianwei Su; Feng Zhang; Yunwei Song; Zhujiang Zhao; Wei Xie
Journal:  BMC Med       Date:  2010-02-03       Impact factor: 8.775

Review 7.  DNA and histone methylation in gastric carcinogenesis.

Authors:  Danielle Queiroz Calcagno; Carolina Oliveira Gigek; Elizabeth Suchi Chen; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

8.  High-throughput strategy to identify inhibitors of histone-binding domains.

Authors:  Elise K Wagner; Brittany N Albaugh; John M Denu
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

9.  DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer.

Authors:  Xue-Yuan Cao; Hong-Xi Ma; Yan-Hong Shang; Mei-Shan Jin; Fei Kong; Zhi-Fang Jia; Dong-Hui Cao; Yin-Ping Wang; Jian Suo; Jing Jiang
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

10.  Correlation of epigenetic aberrance with STAT3 signaling pathway in gastric carcinogenesis.

Authors:  Fuli Gao; Ying Lv; Yinxin Zhu; Min Chen; Shanshan Shen; Jun Cao; Xiaoping Zou
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.